To further support this finding, we had tested and analyzed lung adenocarcinoma biopsy tissue samples using mixed tissue RNA sequencing and found that the JUN gene was statistically associated with successful PD-1 blockade therapy (Figure 5C). This evidence concerns the gene JUN and lung adenocarcinoma.